Join The Cause

Ritalin Side Effects

The documented risks of these drugs are provided so the public can make informed, educated decisions. Ritalin is a stimulant drug, classified by the U.S. Drug Enforcement Administration (DEA) as Schedule II, in the same class of highly addictive drugs as morphine, opium and cocaine. The DEA states that the use of stimulants can lead to “severe psychological or physical dependence” and that “these drugs are also considered dangerous.” Ritalin is also known as Concerta, Concerta LP, Concerta Oros, Daytrana, Equasym, Equasym XL, Metadate, Metadate CD, Metadate ER, Methylin, Methylin ER, Methylphenidate, Ritalin LA, Ritalin SR.

Please note: No one should attempt to get off of psychiatric drugs without doctor’s supervision. To help find medical practitioners in your area, click here.

There have been 32 drug regulatory agency warnings from nine countries (Australia, Canada, Denmark, France, Japan, New Zealand, Singapore, United Kingdom and United States) on Ritalin (or methylphenidate). These include the following (note that some warnings cite more than one side effect, so the list below may not be equal to the total number of warnings):

There have been 25 studies done in 14 countries (Australia, Belgium, Canada, China, Denmark, Germany, Hungary, Ireland, Italy, Netherlands, Scotland, South Korea, United Kingdom and United States) on Ritalin (or methylphenidate). These include the following (note that some studies cite more than one side effect, so the list below may not be equal to the total number of studies):